Anna Grebinyk - Search Results

Year	Number of Results
2018	2
2019	5
2022	2
2023	2
2024	1

1

HPLC-ESI-MS method for C₆₀ fullerene mitochondrial content quantification.

Grebinyk A, Grebinyk S, Prylutska S, Ritter U, Matyshevska O, Dandekar T, Frohme M. Grebinyk A, et al. Data Brief. 2018 Jul 10;19:2047-2052. doi: 10.1016/j.dib.2018.06.089. eCollection 2018 Aug. Data Brief. 2018. PMID: 30229080 Free PMC article.

2

Drug delivery with a pH-sensitive star-like dextran-graft polyacrylamide copolymer.

Grebinyk A, Prylutska S, Grebinyk S, Ponomarenko S, Virych P, Chumachenko V, Kutsevol N, Prylutskyy Y, Ritter U, Frohme M. Grebinyk A, et al. Nanoscale Adv. 2022 Oct 10;4(23):5077-5088. doi: 10.1039/d2na00353h. eCollection 2022 Nov 22. Nanoscale Adv. 2022. PMID: 36504750 Free PMC article.

3

Silent Death by Sound: C₆₀ Fullerene Sonodynamic Treatment of Cancer Cells.

Radivoievych A, Kolp B, Grebinyk S, Prylutska S, Ritter U, Zolk O, Glökler J, Frohme M, Grebinyk A. Radivoievych A, et al. Among authors: grebinyk a. Int J Mol Sci. 2023 Jan 5;24(2):1020. doi: 10.3390/ijms24021020. Int J Mol Sci. 2023. PMID: 36674528 Free PMC article.

4

Comparison of Sonodynamic Treatment Set-Ups for Cancer Cells with Organic Sonosensitizers and Nanosonosensitizers.

Radivoievych A, Prylutska S, Zolk O, Ritter U, Frohme M, Grebinyk A. Radivoievych A, et al. Among authors: grebinyk a. Pharmaceutics. 2023 Nov 11;15(11):2616. doi: 10.3390/pharmaceutics15112616. Pharmaceutics. 2023. PMID: 38004594 Free PMC article.

5

Toxicity of C₆₀ fullerene-cisplatin nanocomplex against Lewis lung carcinoma cells.

Prylutska S, Grynyuk I, Skaterna T, Horak I, Grebinyk A, Drobot L, Matyshevska O, Senenko A, Prylutskyy Y, Naumovets A, Ritter U, Frohme M. Prylutska S, et al. Among authors: grebinyk a. Arch Toxicol. 2019 May;93(5):1213-1226. doi: 10.1007/s00204-019-02441-6. Epub 2019 Apr 15. Arch Toxicol. 2019. PMID: 30989314

6

Synergy of Chemo- and Photodynamic Therapies with C₆₀ Fullerene-Doxorubicin Nanocomplex.

Grebinyk A, Prylutska S, Chepurna O, Grebinyk S, Prylutskyy Y, Ritter U, Ohulchanskyy TY, Matyshevska O, Dandekar T, Frohme M. Grebinyk A, et al. Nanomaterials (Basel). 2019 Oct 30;9(11):1540. doi: 10.3390/nano9111540. Nanomaterials (Basel). 2019. PMID: 31671590 Free PMC article.

7

Toxicity of Water-Soluble D-g-PNIPAM Polymers in a Complex with Chemotherapy Drugs and Mechanism of Their Action In Vitro.

Prylutska S, Grebinyk A, Ponomarenko S, Gövem D, Chumachenko V, Kutsevol N, Petrovsky M, Ritter U, Frohme M, Piosik J, Prylutskyy Y. Prylutska S, et al. Among authors: grebinyk a. Int J Mol Sci. 2024 Mar 6;25(5):3069. doi: 10.3390/ijms25053069. Int J Mol Sci. 2024. PMID: 38474314 Free PMC article.

8

Complexation with C₆₀ Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro.

Grebinyk A, Prylutska S, Grebinyk S, Prylutskyy Y, Ritter U, Matyshevska O, Dandekar T, Frohme M. Grebinyk A, et al. Nanoscale Res Lett. 2019 Feb 20;14(1):61. doi: 10.1186/s11671-019-2894-1. Nanoscale Res Lett. 2019. PMID: 30788638 Free PMC article.

9

C₆₀ Fullerene as an Effective Nanoplatform of Alkaloid Berberine Delivery into Leukemic Cells.

Grebinyk A, Prylutska S, Buchelnikov A, Tverdokhleb N, Grebinyk S, Evstigneev M, Matyshevska O, Cherepanov V, Prylutskyy Y, Yashchuk V, Naumovets A, Ritter U, Dandekar T, Frohme M. Grebinyk A, et al. Pharmaceutics. 2019 Nov 8;11(11):586. doi: 10.3390/pharmaceutics11110586. Pharmaceutics. 2019. PMID: 31717305 Free PMC article.

10

FLASHlab@PITZ: New R&D platform with unique capabilities for electron FLASH and VHEE radiation therapy and radiation biology under preparation at PITZ.

Stephan F, Gross M, Grebinyk A, Aboulbanine Z, Amirkhanyan Z, Budach V, Ehrhardt VH, Faus-Golfe A, Frohme M, Germond JF, Good JD, Grüner F, Kaul D, Krasilnikov M, Leavitt R, Leemans W, Li X, Loisch G, Müller F, Müller G, Obier F, Oppelt A, Philipp S, Qian H, Reindl J, Riemer F, Sack M, Schmitz M, Schnautz T, Schüller A, Staufer T, Stegmann C, Tsakanova G, Vozenin MC, Weise H, Worm S, Zips D. Stephan F, et al. Among authors: grebinyk a. Phys Med. 2022 Dec;104:174-187. doi: 10.1016/j.ejmp.2022.10.026. Epub 2022 Dec 1. Phys Med. 2022. PMID: 36463582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year